All In Biotech

Drug Trial Radar · NCT04056065

PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock

A Prospective, Multi-centric, Randomized, Double-blind, Parallel, Saline Controlled Phase II Safety and Efficacy Study of PMZ-2010 as a Resuscitative Agent for Hypovolemic Shock to be Used Along With Standard Shock Treatment.

Last checked: Nov 20, 2026Latest source record: Aug 14, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

50

Actual

Start

May 29, 2017

Primary completion

Sep 19, 2018

Study completion Oct 21, 2018

Sponsor

Lead sponsor
Pharmazz, Inc.Industry
Sponsor type
Industry
First posted
Aug 14, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, multi-centric, randomized, double-blind, parallel, controlled phase-II efficacy clinical study of PMZ-2010 therapy in patients with hypovolemic shock. Centhaquine is highly safe and well tolerated. Toxicological studies showed high safety margin in preclinical studies. Its safety and tolerability has been demonstrated in a human phase I study in 25 subjects (CTRI/2014/06/004647; NCT02408731).

Conditions

  • Hypovolemic Shock
  • Blood Loss

Interventions

  • Normal SalineDrug

    In addition to standard of care normal saline to be used as vehicle in the phase-II study to assess efficacy of PMZ-2010 as a resuscitative agent for hypovolemic shock

  • CenthaquineDrug

    In addition to standard of care PMZ-2010 to be used as an experimental drug in the phase-II study to assess its efficacy as a resuscitative agent for hypovolemic shock

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of PMZ-2010 related adverse eventsTime frame: 28 days

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • KLE's Dr. Prabhakar Kore Hospital & Medical Research Centre

    Belagavi, India

  • Post Graduate Institute of Medical Education and Research

    Chandigarh, India

  • Institute of Postgraduate Medical Education & Research and SSKM Hospital

    Kolkata, India

  • Dayanand Medical College & Hospital

    Ludhiana, India

  • New Era Hospital & Research Institute

    Nagpur, India

  • ORIANA Hospital

    Varanasi, India

  • Seven Star Hospital

    Nagpur, Maha, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.